Literature DB >> 4402829

The evaluation of histamine antagonists in man.

A S Fowle, D T Hughes, G J Knight.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4402829     DOI: 10.1007/bf00565009

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  7 in total

1.  [The influence of tonsillectomy on iontophoretically induced histamine skin reactions].

Authors:  G STUETTGEN; K FINK; R EULBERG; R NEVELING
Journal:  Allerg Asthma (Leipz)       Date:  1959-12

2.  Quantitative studies in skin testing. V. The whealing reactions of histamine and ragweed pollen extract.

Authors:  H H SWAIN; E L BECKER
Journal:  J Allergy       Date:  1952-09

3.  Quantitative studies in skin testing; the form of the dose-response curve utilizing a quantitative response.

Authors:  E L BECKER; B Z RAPPAPORT
Journal:  J Allergy       Date:  1948-09

4.  Some aspects of the action of histamine antagonists.

Authors:  W A BAIN; F F HELLIER; R P WARIN
Journal:  Lancet       Date:  1948-12-18       Impact factor: 79.321

5.  Comparative skin testing in the antecubital and popliteal spaces.

Authors:  R D WISEMAN
Journal:  J Allergy       Date:  1951-11

6.  A new approach to the use of histamine skin tests in the study of antihistamine drugs.

Authors:  L Joubert; Z Gaut; W B Abrams
Journal:  Clin Pharmacol Ther       Date:  1969 Mar-Apr       Impact factor: 6.875

7.  Comparison of anthisan (mepyramine maleate) and phenergan as histamine antagonists.

Authors:  W A BAIN; J L BROADBENT; R P WARIN
Journal:  Lancet       Date:  1949-07-09       Impact factor: 79.321

  7 in total
  10 in total

1.  Inhibitory activity of terfenadine on histamine-induced skin wheals in man.

Authors:  K J Hüther; G Renftle; N Barraud; J T Burke; J Koch-Weser
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

2.  The clinical assessment of analgesic drugs.

Authors:  D W Littlejohns; D W Vere
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

3.  A comparison of triprolidine and clemastine on histamine antagonism and performance tests in man: implications for the mechanism of drug induced drowsiness.

Authors:  A W Peck; A S Fowle; C Bye
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

4.  A comparison of triprolidine and cyclizine on histamine (H1) antagonism, subjective effects and performance tests in man.

Authors:  M Hamilton; M Bush; C Bye; A W Peck
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

Review 5.  Pharmacologic treatment of rhinitis.

Authors:  F E Simons; K J Simons
Journal:  Clin Rev Allergy       Date:  1984-08

6.  The effect of orally administered triprolidine and pseudoephedrine singly and combined on histamine-induced skin reactions.

Authors:  J R Gibson; K T Medder; K A McDonnell; C E Bye; D T Hughes
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Pharmacodynamic and pharmacokinetics of BW 825C: a new antihistamine.

Authors:  A F Cohen; M J Hamilton; S H Liao; J W Findlay; A W Peck
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Histamine challenge and anterior nasal rhinometry: their use in the assessment of pseudoephedrine and triprolidine as nasal decongestants in subjects with hayfever.

Authors:  M G Britton; D W Empey; G C John; K A McDonnell; D T Hughes
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

9.  Effect of the antihistamines, brompheniramine maleate and triprolidine hydrochloride, on performance in man.

Authors:  A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

10.  Pharmacologic evaluation of loratadine (SCH 29851), chlorpheniramine and placebo.

Authors:  R L Batenhorst; A S Batenhorst; D A Graves; T S Foster; M Kung; R P Gural; H J Amkraut
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.